Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin
- 1 December 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 109 (1-2) , 217-222
- https://doi.org/10.1016/s0304-3835(96)04465-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Lovastatin Inhibits Pancreatic Cancer Growth Regardless of RAS MutationPancreas, 1994
- Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton.Molecular and Cellular Biology, 1994
- Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeuticCell, 1994
- Gap junctional intercellular communication in mouse lung epithelial cell lines: effects of cell transformation and tumor promotersCancer Letters, 1993
- Lovastatin inhibits proliferation of rat mesangial cells.Journal of Clinical Investigation, 1993
- Identification of metabolites of the antitumor agentd-limonene capable of inhibiting protein isoprenylation and cell growthCancer Chemotherapy and Pharmacology, 1992
- Regulation of the mevalonate pathwayNature, 1990
- Ki‐ras activation and expression in transformed mouse lung cell linesMolecular Carcinogenesis, 1990
- All ras proteins are polyisoprenylated but only some are palmitoylatedCell, 1989
- ras GENESAnnual Review of Biochemistry, 1987